Logo image of CAMT

CAMTEK LTD (CAMT) Stock Fundamental Analysis

USA - NASDAQ:CAMT - IL0010952641 - Common Stock

97.61 USD
-3.54 (-3.5%)
Last: 9/19/2025, 8:00:02 PM
98.29 USD
+0.68 (+0.7%)
After Hours: 9/19/2025, 8:00:02 PM
Fundamental Rating

6

CAMT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. While CAMT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CAMT shows excellent growth, but is valued quite expensive already. These ratings could make CAMT a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

CAMT had positive earnings in the past year.
CAMT had positive earnings in each of the past 5 years.
In the past 5 years CAMT always reported a positive cash flow from operatings.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

With an excellent Return On Assets value of 13.72%, CAMT belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Looking at the Return On Equity, with a value of 21.36%, CAMT belongs to the top of the industry, outperforming 86.61% of the companies in the same industry.
The Return On Invested Capital of CAMT (13.47%) is better than 86.61% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CAMT is in line with the industry average of 10.87%.
The last Return On Invested Capital (13.47%) for CAMT is above the 3 year average (11.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.72%
ROE 21.36%
ROIC 13.47%
ROA(3y)11.71%
ROA(5y)10.6%
ROE(3y)19.67%
ROE(5y)17.82%
ROIC(3y)11.43%
ROIC(5y)11.2%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

CAMT's Profit Margin of 28.38% is amongst the best of the industry. CAMT outperforms 87.50% of its industry peers.
CAMT's Profit Margin has improved in the last couple of years.
CAMT's Operating Margin of 26.86% is amongst the best of the industry. CAMT outperforms 86.61% of its industry peers.
CAMT's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 50.46%, CAMT is doing good in the industry, outperforming 63.39% of the companies in the same industry.
In the last couple of years the Gross Margin of CAMT has remained more or less at the same level.
Industry RankSector Rank
OM 26.86%
PM (TTM) 28.38%
GM 50.46%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.46%
PM growth 5Y11.08%
GM growth 3Y-0.69%
GM growth 5Y0.63%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CAMT is still creating some value.
Compared to 1 year ago, CAMT has more shares outstanding
The number of shares outstanding for CAMT has been increased compared to 5 years ago.
CAMT has a better debt/assets ratio than last year.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

CAMT has an Altman-Z score of 9.89. This indicates that CAMT is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 9.89, CAMT is doing good in the industry, outperforming 74.11% of the companies in the same industry.
CAMT has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CAMT (0.32) is worse than 63.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 9.89
ROIC/WACC1.17
WACC11.5%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

CAMT has a Current Ratio of 5.41. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
CAMT has a better Current ratio (5.41) than 76.79% of its industry peers.
A Quick Ratio of 4.38 indicates that CAMT has no problem at all paying its short term obligations.
With a decent Quick ratio value of 4.38, CAMT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.41
Quick Ratio 4.38
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

CAMT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.80%, which is quite impressive.
The Earnings Per Share has been growing by 34.86% on average over the past years. This is a very strong growth
CAMT shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.82%.
Measured over the past years, CAMT shows a very strong growth in Revenue. The Revenue has been growing by 26.20% on average per year.
EPS 1Y (TTM)30.8%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%19.7%
Revenue 1Y (TTM)27.82%
Revenue growth 3Y16.74%
Revenue growth 5Y26.2%
Sales Q2Q%20.2%

3.2 Future

CAMT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.41% yearly.
CAMT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.97% yearly.
EPS Next Y15.63%
EPS Next 2Y12.7%
EPS Next 3Y12.44%
EPS Next 5Y16.41%
Revenue Next Year15.52%
Revenue Next 2Y11.88%
Revenue Next 3Y11.79%
Revenue Next 5Y15.97%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.49, CAMT can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CAMT is valued a bit cheaper than the industry average as 68.75% of the companies are valued more expensively.
CAMT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 27.35 indicates a quite expensive valuation of CAMT.
CAMT's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CAMT to the average of the S&P500 Index (22.86), we can say CAMT is valued inline with the index average.
Industry RankSector Rank
PE 31.49
Fwd PE 27.35
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

60.71% of the companies in the same industry are more expensive than CAMT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.86
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CAMT may justify a higher PE ratio.
A more expensive valuation may be justified as CAMT's earnings are expected to grow with 12.44% in the coming years.
PEG (NY)2.01
PEG (5Y)0.9
EPS Next 2Y12.7%
EPS Next 3Y12.44%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CAMT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAMTEK LTD

NASDAQ:CAMT (9/19/2025, 8:00:02 PM)

After market: 98.29 +0.68 (+0.7%)

97.61

-3.54 (-3.5%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-10 2025-11-10/bmo
Inst Owners53.03%
Inst Owner Change-2.74%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap4.46B
Analysts82.5
Price Target101.08 (3.55%)
Short Float %13.29%
Short Ratio9.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.33
Dividend Growth(5Y)56.87%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.87%
Min EPS beat(2)-2.25%
Max EPS beat(2)0.51%
EPS beat(4)3
Avg EPS beat(4)1.36%
Min EPS beat(4)-2.25%
Max EPS beat(4)6.06%
EPS beat(8)7
Avg EPS beat(8)2.75%
EPS beat(12)10
Avg EPS beat(12)2.39%
EPS beat(16)12
Avg EPS beat(16)2.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-2.27%
Max Revenue beat(2)-0.59%
Revenue beat(4)1
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.3%
Revenue beat(12)2
Avg Revenue beat(12)-0.68%
Revenue beat(16)3
Avg Revenue beat(16)-0.74%
PT rev (1m)9.5%
PT rev (3m)16.44%
EPS NQ rev (1m)-0.17%
EPS NQ rev (3m)-0.72%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.64%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.68%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.76%
Valuation
Industry RankSector Rank
PE 31.49
Fwd PE 27.35
P/S 9.46
P/FCF N/A
P/OCF N/A
P/B 7.11
P/tB 8.25
EV/EBITDA 33.86
EPS(TTM)3.1
EY3.18%
EPS(NY)3.57
Fwd EY3.66%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.31
BVpS13.72
TBVpS11.84
PEG (NY)2.01
PEG (5Y)0.9
Profitability
Industry RankSector Rank
ROA 13.72%
ROE 21.36%
ROCE 14.98%
ROIC 13.47%
ROICexc 13.47%
ROICexgc 14.99%
OM 26.86%
PM (TTM) 28.38%
GM 50.46%
FCFM N/A
ROA(3y)11.71%
ROA(5y)10.6%
ROE(3y)19.67%
ROE(5y)17.82%
ROIC(3y)11.43%
ROIC(5y)11.2%
ROICexc(3y)23.25%
ROICexc(5y)34.93%
ROICexgc(3y)26.06%
ROICexgc(5y)36.79%
ROCE(3y)12.71%
ROCE(5y)12.46%
ROICexcg growth 3Y-39.43%
ROICexcg growth 5Y-18.22%
ROICexc growth 3Y-41.68%
ROICexc growth 5Y-20%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.46%
PM growth 5Y11.08%
GM growth 3Y-0.69%
GM growth 5Y0.63%
F-ScoreN/A
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 1.44
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.41
Quick Ratio 4.38
Altman-Z 9.89
F-ScoreN/A
WACC11.5%
ROIC/WACC1.17
Cap/Depr(3y)145.49%
Cap/Depr(5y)140.52%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.15%
Profit Quality(3y)82.13%
Profit Quality(5y)89.36%
High Growth Momentum
Growth
EPS 1Y (TTM)30.8%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%19.7%
EPS Next Y15.63%
EPS Next 2Y12.7%
EPS Next 3Y12.44%
EPS Next 5Y16.41%
Revenue 1Y (TTM)27.82%
Revenue growth 3Y16.74%
Revenue growth 5Y26.2%
Sales Q2Q%20.2%
Revenue Next Year15.52%
Revenue Next 2Y11.88%
Revenue Next 3Y11.79%
Revenue Next 5Y15.97%
EBIT growth 1Y48.56%
EBIT growth 3Y16.58%
EBIT growth 5Y38.59%
EBIT Next Year23.07%
EBIT Next 3Y17.33%
EBIT Next 5Y19.53%
FCF growth 1Y57.63%
FCF growth 3Y25.41%
FCF growth 5Y36.93%
OCF growth 1Y53.8%
OCF growth 3Y26.02%
OCF growth 5Y37.72%